These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38393536)

  • 41. Plausible role of bacterial toxin-antitoxin system in persister cell formation and elimination.
    Paul P; Sahu BR; Suar M
    Mol Oral Microbiol; 2019 Jun; 34(3):97-107. PubMed ID: 30891951
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Environmental Stress Affects the Formation of Staphylococcus aureus Persisters Tolerant to Antibiotics.
    Kubistova L; Dvoracek L; Tkadlec J; Melter O; Licha I
    Microb Drug Resist; 2018 Jun; 24(5):547-555. PubMed ID: 28813617
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pseudomonas aeruginosa persister cell formation upon antibiotic exposure in planktonic and biofilm state.
    Patel H; Buchad H; Gajjar D
    Sci Rep; 2022 Sep; 12(1):16151. PubMed ID: 36168027
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Unravelling the physiological roles of mazEF toxin-antitoxin system on clinical MRSA strain by CRISPR RNA-guided cytidine deaminase.
    Jain S; Bhowmick A; Jeong B; Bae T; Ghosh A
    J Biomed Sci; 2022 May; 29(1):28. PubMed ID: 35524246
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative analysis of five type II TA systems identified in
    Song Y; Tang H; Bao R
    Front Cell Infect Microbiol; 2023; 13():1127786. PubMed ID: 36844395
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Post-transcriptional deregulation of the tisB/istR-1 toxin-antitoxin system promotes SOS-independent persister formation in Escherichia coli.
    Edelmann D; Oberpaul M; Schäberle TF; Berghoff BA
    Environ Microbiol Rep; 2021 Apr; 13(2):159-168. PubMed ID: 33350069
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interaction of Staphylococcus aureus persister cells with the host when in a persister state and following awakening.
    Mina EG; Marques CN
    Sci Rep; 2016 Aug; 6():31342. PubMed ID: 27506163
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Study of MazEF, sam, and phd-doc putative toxin-antitoxin systems in Staphylococcus epidermidis.
    Behrooz SK; Lida L; Ali S; Mehdi M; Rasoul M; Elnaz O; Farid BT; Gholamreza I
    Acta Microbiol Immunol Hung; 2018 Mar; 65(1):81-91. PubMed ID: 29471693
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeting Type II Toxin-Antitoxin Systems as Antibacterial Strategies.
    Równicki M; Lasek R; Trylska J; Bartosik D
    Toxins (Basel); 2020 Sep; 12(9):. PubMed ID: 32899634
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bacterial Type I Toxins: Folding and Membrane Interactions.
    Nonin-Lecomte S; Fermon L; Felden B; Pinel-Marie ML
    Toxins (Basel); 2021 Jul; 13(7):. PubMed ID: 34357962
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Staphylococcal Bacterial Persister Cells, Biofilms, and Intracellular Infection Are Disrupted by JD1, a Membrane-Damaging Small Molecule.
    Dombach JL; Quintana JLJ; Detweiler CS
    mBio; 2021 Oct; 12(5):e0180121. PubMed ID: 34634935
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The MqsRA Toxin-Antitoxin System from Xylella fastidiosa Plays a Key Role in Bacterial Fitness, Pathogenicity, and Persister Cell Formation.
    Merfa MV; Niza B; Takita MA; De Souza AA
    Front Microbiol; 2016; 7():904. PubMed ID: 27375608
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A novel Staphylococcus aureus cis-trans type I toxin-antitoxin module with dual effects on bacteria and host cells.
    Germain-Amiot N; Augagneur Y; Camberlein E; Nicolas I; Lecureur V; Rouillon A; Felden B
    Nucleic Acids Res; 2019 Feb; 47(4):1759-1773. PubMed ID: 30544243
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of gene expression and protein structural modeling involved in persister cell formation in Salmonella Typhimurium.
    Narimisa N; Amraei F; Kalani BS; Jazi FM
    Braz J Microbiol; 2021 Mar; 52(1):207-217. PubMed ID: 33125683
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification and characterization of the type II toxin-antitoxin systems in the carbapenem-resistant Acinetobacterbaumannii.
    Japoni-Nejad A; Mood EH; Ehsani P; Sardari S; Heravi FS; Bouzari S; Shahrokhi N
    Microb Pathog; 2021 Sep; 158():105052. PubMed ID: 34147586
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    Nasser A; Jahanbakhshi S; Soltan Dallal MM; Banar M; Sattari-Maraji A; Azimi T
    Curr Pharm Biotechnol; 2023; 24(15):1898-1915. PubMed ID: 37055886
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Magnesium Links Starvation-Mediated Antibiotic Persistence to ATP.
    Xu T; Wang X; Meng L; Zhu M; Wu J; Xu Y; Zhang Y; Zhang W
    mSphere; 2020 Jan; 5(1):. PubMed ID: 31915231
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Emergence of persister cells in
    Vasudevan S; David H; Chanemougam L; Ramani J; Ramesh Sangeetha M; Solomon AP
    Crit Rev Microbiol; 2024 Feb; 50(1):64-75. PubMed ID: 36548910
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The MazEF Toxin-Antitoxin System Alters the β-Lactam Susceptibility of Staphylococcus aureus.
    Schuster CF; Mechler L; Nolle N; Krismer B; Zelder ME; Götz F; Bertram R
    PLoS One; 2015; 10(5):e0126118. PubMed ID: 25965381
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HigB of
    Li M; Long Y; Liu Y; Liu Y; Chen R; Shi J; Zhang L; Jin Y; Yang L; Bai F; Jin S; Cheng Z; Wu W
    Front Cell Infect Microbiol; 2016; 6():125. PubMed ID: 27790409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.